Scientific advisory board
Our Scientific Advisory Board is composed of the key opinion leaders in immunotherapy and food allergy worldwide.
Pr. Christophe Dupont
Dr. Hugh Sampson
Hugh A. Sampson, M.D., is a professor of Pediatrics and Immunobiology at the Mount Sinai School of Medicine, N.Y., USA. He is Chief of the Division of Allergy & Immunology in the Department of Pediatrics; Director of the Jaffe Food Allergy Institute; and Dean of Translational Biomedical Science at The Mount Sinai Medical Center. He received his M.D. from the Buffalo State University of New York School of Medicine. Dr. Sampson's research interests have focused on food allergic disorders, including work on the immuno-pathogenic role of food hypersensitivity in atopic dermatitis, the pathogenesis of food-induced anaphylaxis, the characterization of food-induced gastrointestinal hypersensitivities, the characterization of food allergens, and novel immunotherapeutic strategies (recombinant engineered protein, plasmid DNA, peptide, etc.) for treating food allergies. His research has been funded by a number of grants from the National Institutes of Health (NIH) and private foundations (Clarissa Sosin Foundation and Food Allergy Initiative). He is the Principal Investigator of the NIH-sponsored Consortium of Food Allergy Research (COFAR). He is also former President of the American Academy of Allergy Asthma and Immunology (AAAAI).
Pr. Franklin Adkinson
Dr. Motohiro Ebisawa
The Professor Ebisawa, MD, PhD, is Director of Allergy at Sagamihara National Hospital in Kanagawa (Japan) is a leading expert in food allergies. He currently serves as Secretary General on the Board of Directors of the World Allergy Organization (WAO), where he has served in different leadership roles since 2010. In addition to his WAO tenure, Dr. Ebisawa serves on the Executive Board of Directors of the Japanese Society of Allergology, is Chair of the Food Allergy Committee of the Japanese Society of Pediatric Allergy and Clinical Immunology, and is a member of the GINA Assembly and the Collegium Internationale Allergogicum (CIA).
Pr. Philippe Eigenmann
Pr. Gideon Lack
Pr. Paul Henri Lambert
Professor Paul-Henri Lambert, MD, is directing the International Advanced Course of Vaccinology (ADVAC) and is associated with the Centre of Vaccinology at University of Geneva. He is an expert in vaccination strategies and assessment of vaccine adverse effects. He is former chief of Microbiology and Immunology and Vaccine Research and Development programs at the World Health Organization (WHO). He also chaired the WHO Global Advisory Committee for Vaccine Safety.
Dr. Jacques-Pierre Moreau
Dr Moreau has broad industry experience across the spectrum of drug discovery, development and commercialization. He has published over 50 articles in scientific journals and is named inventor or co-inventor in over 40 U.S. issued patents. He has been founder or co-founder of successful biotechs such as Biomeasure, Inc. (MA, U.S.A.), Kinerton, Ltd. (Ireland), ProteoThera (MA, U.S.A.) and Mulleris Therapeutics (MA, U.S.A.). Dr. Moreau is the former Chief Scientific Officer and Executive Vice-President for Ipsen SA (France). Active contributor to Ipsen’s IPO in 2005 and to the spin-offs of Preglem (CH), Radius Health, Inc. (MA, U.S.A.), Functional Therapeutics (U.K./CH) and Rhythm Pharmaceuticals (MA, U.S.A.). Dr. Moreau is a Director of Dr. Reddy’s Laboratories Ltd (India), member of the Science, Technology, Strategy and Risk committees. He is also former board member of Phytochemics, an Inventage Venture-funded company, former advisor for Nitto Denko & Teijin Pharmaceutical (Japan) and current advisor for Genosys (U.S.A.), and Banque Oddo (France). Dr. J Moreau holds a master’s degree in physical chemistry and was awarded a D.Sc from the University of Orleans, France based on doctoral studies conducted at the Worcester Foundation for Experimental Biology (now part of U-Mass), followed by post-doctoral studies at the École Polytechnique in Paris.
Pr. Jonathan M. Spergel
Pr. Robert Zeiger
Professor Zeiger, MD, PhD, is a Clinical Professor in the Department of Pediatrics at the UCSD School of Medicine in La Jolla, California, United States, and Adjunct Physician Investigator for Kaiser Permanente Southern California. In addition, Professor Zeiger serves on the Medical Advisory Board for Food Allergy Research and Education (FARE) and Deputy Editor for the Journal of Allergy Clinical Immunology: In Practice. Professor Zeiger’s current research activities focus on childhood asthma prevention and outcomes research.